{"name":"Lumen Bioscience, Inc.","slug":"lumen-bioscience-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"LMN-101","genericName":"LMN-101","slug":"lmn-101","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"LMN-101","genericName":"LMN-101","slug":"lmn-101","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNUWxocS1uZjlveVdGRU85S0lMMDZ1cXZqNHVnNzRUdFZUVGFVWGVmNWtZTElMRTEwb1dlZ2FIT0tvRjlZMUJoTjgwSEtWX0l2aFdGRTgzUFROT3ZsajZEQ0RxSkQ3eDFtZWs3N3JoLWJpTURadkhLSkVYY09Kai02VXBvTUdJS2cyRkRmMlp4S0NVMXA5LVVLcm9Nc1I2R1RBTE5zUTBvckd0QWFYQWxjNFRVVlVIX0ZvSWRrWlhPTmtWT3NZR3hwejRIRDJZUlZxZ05pd0hFbEZndjBuYXllNE5yQThyckQ0dW91aEMyeEhpOWlBTEhKSQ?oc=5","date":"2026-04-07","type":"pipeline","source":"Barchart.com","summary":"Clostridium Difficile Infections Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"Clostridium Difficile Infections Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveIns","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQWXA4M0ljajFJQnZaT3gtYWlEZWMweF9NdVNmM3dYUnA4X2c0c1NaclFwQlIxOGJWQkEwSGFkTEhzeWVpT3NRQ0RQeVVhUTZhQk54N0RrZnNBSXdtS0tkdEFDbVJ0S3daR0hqYkl0eWpBcThGMVlhVWd6ZE94dmtnRDJ0bU1KaVpOTGUyXzhTRXlNMjJNbnJDOHYtUmd2NVNoak5GZWJQTlU5RlV5UkZkQjZ6OEhBcGpyUjhaUkNoQlZZSzZXRmJhaTUxMDhCWXNI?oc=5","date":"2026-02-23","type":"pipeline","source":"Citeline News & Insights","summary":"20 Voices: What Does 2026 Hold For Biopharma? - Citeline News & Insights","headline":"20 Voices: What Does 2026 Hold For Biopharma? - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE9BdjR3eXRaTU41dGJfN0wxWHc3UmJyUGc5SkhwUXI5czB1T05fWFdGZG1VWFRGd0dGTW9BUXhMVkkzcVhXbHBha3VhTG1fbmlCbS0yc2ZJWExscnJ5VDYxR3NlM1NnOWtJLVgzbDY2LWFhQQ?oc=5","date":"2025-11-11","type":"pipeline","source":"Labiotech.eu","summary":"Seattle top biotechs 2025: the 9 companies you should now about - Labiotech.eu","headline":"Seattle top biotechs 2025: the 9 companies you should now about","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5GcGhkMkRRZ0hfTmVya3UwYi12WGE3Y0ZsN05oZFBBNExUSkxaNFRnMEVIQjlYa21Bam55VGlQVElUQmRwdWJyR3R5VENTSnhtOG5aWldrRWhITFlYdGhROWlfSUpoUEJWY0pFc3F6ZGlPTC1PRXltdklCOA?oc=5","date":"2025-11-05","type":"trial","source":"Market Data Forecast","summary":"Oral Biologics Market Size, Share & Growth Report, 2033 - Market Data Forecast","headline":"Oral Biologics Market Size, Share & Growth Report, 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxQeWI0am9wb0tYc2hTV29mYzgzRGQwLV9RUURQS0gwcWNjUHpsa0Q3QWF2QnRDTTEzQzdDdmM5anlwTDl5anRIb3doOHhQLUxFeVBzQmpTSXBxR3Z4WlZtejZKZi1DNFE0X3lySTdiajZuSXJYV0h1OFlrblg3SncwSGRDYy14ZE04MU5BaHctMzhqQndOOThFMkRYakxhSmIzYTVLQWcxazNucFJ0QllWRm9BNFZURmpSTFpTVThUMHgxUUJ3QXAyT3g0dVlacmZlaGVMdHJKOW1GLVFmMmRZaVQ5dF90TkNPNHp2OHVvYUc?oc=5","date":"2025-10-08","type":"pipeline","source":"PR Newswire","summary":"Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics - PR Newswire","headline":"Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQMzVuQjlSSHJjeFFYRTF3WFJQM0RRVzJ4TTBreWk4UXNFZjdWTTdhM0hqNEJyY3VOaldwRmNFZG02NkJEaWVqREstbE83c0FLc1BES0N6OWctcmMybkFrTll5UFF2VHJFaGo5b0pNdzZjamhUY0l6RnFvQ20wenFkVFcza2pNTEtsVVhDNlJ0a2J1cWdZVEZCYmVYWGNvWkpPM19hejNOamZuVW5nM2ZxQUV4YmduMlh0Z3ZxX1p6Vmo?oc=5","date":"2025-10-08","type":"pipeline","source":"GeekWire","summary":"Fresh off $30M round, Seattle startup Lumen Bioscience adds Microsoft vet Jeff Raikes to board - GeekWire","headline":"Fresh off $30M round, Seattle startup Lumen Bioscience adds Microsoft vet Jeff Raikes to board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE13OWRKVjdOblNySjZGWlotRUw5TWF6TXZnMUZaWDFLaHQ3T3N5eExMWHZ6RmgxdHNYOW9MZF9BaDFnQU1mMno5WUc3ZV9UNF8ybmNWU3FnOWUxOE1PbEFHQVN2akVJeDlWQmlBbWxHMHJCU0kwWmF5b1UyQ2NmaHM?oc=5","date":"2025-10-08","type":"pipeline","source":"Axios","summary":"Lumen Bioscience raises $30M Series C extension - Axios","headline":"Lumen Bioscience raises $30M Series C extension","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxNQnZaOHUwbWFabkV0RFAwSE4tQjNxVG5pNnFGWjFiNHlnbGI5SjBUc1pJblMydnpYN3NoV25ZcGlpdmdLM25nM0JHZVB1dnNGOGpvQjlhZ1Z3SFdFQjFPYWk3TnItRXJHeXRpTXctS1Q3RG5KVjF5MGVWX1d6eXM4RE5leUVMY0MtWUtoV0ZWeHZTb0UwZUM4bG95RkFUS25NWHdSVEwwRVF1OHNocUxiQTJvandOZ0J5aHpjVWlVRGpmYXNnbGtEcUZUQXJnN1Jmd0QxTjlvSFJKS21OY2djaVRhR2R2bnFQRHNBXzB4eDhTX3JNdnM5MWYzNk1Gc3p2WXcwakpNZlAzT3IyZzZaRjFhRG9MUGo5ZnNKODhVNWI4UXdqYV9JTTMtSDQtVEJKWHBvRm5ldDlWczFxWEdYaw?oc=5","date":"2025-09-02","type":"pipeline","source":"PR Newswire UK","summary":"Clostridioides difficile Infection Market Forecasts by DelveInsight Signal Groundbreaking Growth at a CAGR of 13.5% in the 7MM during the Forecast Period (2025-2034) - PR Newswire UK","headline":"Clostridioides difficile Infection Market Forecasts by DelveInsight Signal Groundbreaking Growth at a CAGR of 13.5% in t","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPTDM1b0luY1J1azFEeDZYay1hQzB2NFFkZ01kVUxDR3cta3pBRDZSY011aUZZMUdKV3Q5akljdFlPdXNWUmc1SHljcklnOXJPS2VTWFdveXFEaGJ0dnl5eFA0Rnpmd3pMZUpwR0ZZRjU0NXZhZS1fUEtVdVowTDEtOEdKWjBOaFM3bmRReU51RWJqZjJE?oc=5","date":"2023-09-26","type":"pipeline","source":"Fast Company","summary":"Cows burp out too much methane. This biotech startup is making a bovine Beano - Fast Company","headline":"Cows burp out too much methane. This biotech startup is making a bovine Beano","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxQRER6c0V3U0NPX2JjWlVvN1pXbURGTWp5N3Exbi1tc0RJSXFOLURXbWRBMmlkdkxRWXRVVWE2TzBzOXRFMV9mMWJNaklHWW5WQ0lOaThURVo4MTN0R2RuRGZ5RTYyMkhOSUVKLTJhR3FpZE5wUXl1MXlhSEZid2R1a3NMWWIzaEh3cm9DaXQ0U3Vxbmt1U0hmRUlkZ2lFdThnd2tCQmhsNThQa3NJOEh1dmdIc2x4dnlRUFlQdjJISUdFWGlOcU50WDJTRTB2LUNPeTE5LWZGLWkzbWhYTzd4ZExNOWVxYUZiT1IxbUhRdw?oc=5","date":"2023-01-05","type":"pipeline","source":"PR Newswire","summary":"Lumen Bioscience Details 2022 Company and Facilities Growth, New Funding, and Clinical Pipeline Progress - PR Newswire","headline":"Lumen Bioscience Details 2022 Company and Facilities Growth, New Funding, and Clinical Pipeline Progress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1nOTgxMzhhXy1MbTB6T2JxMk1ONVdNdUhJQmRfNHhXbVJZaEk1UXltczFsSER0ZFROLXZsTUFQWUh6cFZZUTlobXRXUGVEQ1hyXy1QSExHbG1ncHlKQkRz?oc=5","date":"2022-03-21","type":"pipeline","source":"Nature","summary":"Development of spirulina for the manufacture and oral delivery of protein therapeutics - Nature","headline":"Development of spirulina for the manufacture and oral delivery of protein therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPUHpuZHlzTEVnd3JJUEhiT0J2R1JzbWtIYmh5NkFMWUVFYkQ3UUR1a195cmM4d0hQeGg0V3IxOGpyLUp5MU9PaC00VHlyU3gtSnNma0dobzBwZWNkZmtQWk9BdmpfM1RRMkNjVFVXOVhQUHRKMm5mbkM4b1RIVkk1NzAyeTFpejJzcXlEa2JWcHRaNEZ5Z1U1OEhqbnFKXzJTaTZULQ?oc=5","date":"2018-07-09","type":"pipeline","source":"The Business Journals","summary":"Lumen Bioscience hires executive to scale blue-green algae technology - The Business Journals","headline":"Lumen Bioscience hires executive to scale blue-green algae technology","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}